【24h】

Evolutionary epidemiology 20 years on: Challenges and prospects

机译:进化流行病学20年:挑战与前景

获取原文
获取原文并翻译 | 示例
       

摘要

The advent of molecular biology has deeply impacted the study of infectious diseases and their epidemiology in particular. However, evolutionary biology, which provides an essential conceptual framework to understand the observed patterns of genetic and phenotypic diversity, is still lacking the attention it deserves from the medical community. In 1988, Paul Ewald coined the term evolutionary epidemiology to describe a systematic approach to the evolution of pathogen virulence. This review seeks to cast a new light on evolutionary epidemiology beyond Ewald's seminal project. While ecologists and evolutionary biologists have developed powerful theoretical tools to help us understand pathogen evolution, more work is needed across traditional disciplines in order to analyse and tackle the unabated spread of hypervirulence, drug resistance and antigenic escape. I review a number of cases where evolutionary biology has played or could play a leading role in the design of novel medical approaches.
机译:分子生物学的到来尤其对传染病及其流行病学的研究产生了深远的影响。然而,进化生物学提供了一个基本的概念框架来理解观察到的遗传和表型多样性的模式,但仍缺乏医学界的关注。 1988年,Paul Ewald创造了“进化流行病学”一词来描述病原体毒力进化的系统方法。这篇综述旨在为进化流行病学提供新的视角,超越埃瓦尔德的开创性研究。尽管生态学家和进化生物学家已经开发了强大的理论工具来帮助我们了解病原体的进化,但传统学科仍需要做更多的工作,以便分析和解决高毒力,耐药性和抗原逃逸的不断蔓延。我回顾了进化生物学在新型医学方法的设计中起着或可能起着主导作用的许多情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号